nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—Ticagrelor—coronary artery disease	0.0454	0.0699	CbGbCtD
Reboxetine—ABCB1—Clopidogrel—coronary artery disease	0.0281	0.0432	CbGbCtD
Reboxetine—ABCB1—Perindopril—coronary artery disease	0.0281	0.0432	CbGbCtD
Reboxetine—CYP3A4—Ticagrelor—coronary artery disease	0.0272	0.0419	CbGbCtD
Reboxetine—ABCB1—Telmisartan—coronary artery disease	0.0245	0.0377	CbGbCtD
Reboxetine—ABCB1—Pitavastatin—coronary artery disease	0.0245	0.0377	CbGbCtD
Reboxetine—CYP3A4—Fenofibrate—coronary artery disease	0.0243	0.0373	CbGbCtD
Reboxetine—ABCB1—Enalapril—coronary artery disease	0.0233	0.0358	CbGbCtD
Reboxetine—ABCB1—Lisinopril—coronary artery disease	0.0233	0.0358	CbGbCtD
Reboxetine—CYP2D6—Niacin—coronary artery disease	0.02	0.0308	CbGbCtD
Reboxetine—ABCB1—Timolol—coronary artery disease	0.0198	0.0304	CbGbCtD
Reboxetine—CYP3A4—Gemfibrozil—coronary artery disease	0.0194	0.0298	CbGbCtD
Reboxetine—CYP2D6—Timolol—coronary artery disease	0.0186	0.0287	CbGbCtD
Reboxetine—ABCB1—Ezetimibe—coronary artery disease	0.0181	0.0278	CbGbCtD
Reboxetine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0176	0.0271	CbGbCtD
Reboxetine—ABCB1—Captopril—coronary artery disease	0.0174	0.0268	CbGbCtD
Reboxetine—CYP3A4—Clopidogrel—coronary artery disease	0.0168	0.0259	CbGbCtD
Reboxetine—ABCB1—Simvastatin—coronary artery disease	0.0168	0.0259	CbGbCtD
Reboxetine—ABCB1—Pravastatin—coronary artery disease	0.0165	0.0253	CbGbCtD
Reboxetine—ABCB1—Lovastatin—coronary artery disease	0.0165	0.0253	CbGbCtD
Reboxetine—CYP2D6—Captopril—coronary artery disease	0.0164	0.0252	CbGbCtD
Reboxetine—CYP2D6—Simvastatin—coronary artery disease	0.0158	0.0244	CbGbCtD
Reboxetine—CYP3A4—Eplerenone—coronary artery disease	0.0156	0.024	CbGbCtD
Reboxetine—CYP2D6—Lovastatin—coronary artery disease	0.0155	0.0238	CbGbCtD
Reboxetine—CYP2D6—Pravastatin—coronary artery disease	0.0155	0.0238	CbGbCtD
Reboxetine—ABCB1—Atorvastatin—coronary artery disease	0.015	0.023	CbGbCtD
Reboxetine—CYP2D6—Atorvastatin—coronary artery disease	0.0141	0.0217	CbGbCtD
Reboxetine—CYP3A4—Enalapril—coronary artery disease	0.0139	0.0214	CbGbCtD
Reboxetine—ABCB1—Losartan—coronary artery disease	0.0137	0.0211	CbGbCtD
Reboxetine—CYP3A4—Rosuvastatin—coronary artery disease	0.0108	0.0167	CbGbCtD
Reboxetine—CYP3A4—Ezetimibe—coronary artery disease	0.0108	0.0167	CbGbCtD
Reboxetine—CYP3A4—Simvastatin—coronary artery disease	0.0101	0.0155	CbGbCtD
Reboxetine—CYP3A4—Pravastatin—coronary artery disease	0.00986	0.0152	CbGbCtD
Reboxetine—CYP3A4—Lovastatin—coronary artery disease	0.00986	0.0152	CbGbCtD
Reboxetine—CYP3A4—Atorvastatin—coronary artery disease	0.00898	0.0138	CbGbCtD
Reboxetine—CYP3A4—Losartan—coronary artery disease	0.00821	0.0126	CbGbCtD
Reboxetine—Cyclizine—SULT1E1—coronary artery disease	0.00236	0.457	CrCbGaD
Reboxetine—Phenprocoumon—VKORC1—coronary artery disease	0.00195	0.377	CrCbGaD
Reboxetine—Benzatropine—CYP2C19—coronary artery disease	0.000266	0.0515	CrCbGaD
Reboxetine—Atomoxetine—CYP2C19—coronary artery disease	0.00017	0.0328	CrCbGaD
Reboxetine—Phenprocoumon—ALB—coronary artery disease	0.00015	0.0291	CrCbGaD
Reboxetine—Atomoxetine—HTR2A—coronary artery disease	0.000137	0.0266	CrCbGaD
Reboxetine—Diphenhydramine—CYP2C19—coronary artery disease	0.000137	0.0265	CrCbGaD
Reboxetine—Dermatitis—Clopidogrel—coronary artery disease	9.79e-05	0.000361	CcSEcCtD
Reboxetine—Asthenia—Valsartan—coronary artery disease	9.79e-05	0.000361	CcSEcCtD
Reboxetine—Hypertension—Timolol—coronary artery disease	9.78e-05	0.000361	CcSEcCtD
Reboxetine—Constipation—Furosemide—coronary artery disease	9.78e-05	0.000361	CcSEcCtD
Reboxetine—Hypersensitivity—Niacin—coronary artery disease	9.77e-05	0.000361	CcSEcCtD
Reboxetine—Ill-defined disorder—Lisinopril—coronary artery disease	9.75e-05	0.00036	CcSEcCtD
Reboxetine—Discomfort—Ramipril—coronary artery disease	9.75e-05	0.00036	CcSEcCtD
Reboxetine—Asthenia—Olmesartan—coronary artery disease	9.74e-05	0.00036	CcSEcCtD
Reboxetine—Headache—Clopidogrel—coronary artery disease	9.74e-05	0.000359	CcSEcCtD
Reboxetine—Rash—Lovastatin—coronary artery disease	9.74e-05	0.000359	CcSEcCtD
Reboxetine—Dermatitis—Lovastatin—coronary artery disease	9.73e-05	0.000359	CcSEcCtD
Reboxetine—Anaemia—Lisinopril—coronary artery disease	9.72e-05	0.000359	CcSEcCtD
Reboxetine—Dyspepsia—Losartan—coronary artery disease	9.71e-05	0.000358	CcSEcCtD
Reboxetine—Feeling abnormal—Perindopril—coronary artery disease	9.69e-05	0.000358	CcSEcCtD
Reboxetine—Headache—Lovastatin—coronary artery disease	9.67e-05	0.000357	CcSEcCtD
Reboxetine—Dry mouth—Ramipril—coronary artery disease	9.65e-05	0.000356	CcSEcCtD
Reboxetine—Chest pain—Timolol—coronary artery disease	9.65e-05	0.000356	CcSEcCtD
Reboxetine—Vomiting—Ezetimibe—coronary artery disease	9.63e-05	0.000355	CcSEcCtD
Reboxetine—Hypersensitivity—Pravastatin—coronary artery disease	9.62e-05	0.000355	CcSEcCtD
Reboxetine—Gastrointestinal pain—Perindopril—coronary artery disease	9.62e-05	0.000355	CcSEcCtD
Reboxetine—Anxiety—Timolol—coronary artery disease	9.61e-05	0.000355	CcSEcCtD
Reboxetine—Decreased appetite—Losartan—coronary artery disease	9.59e-05	0.000354	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.58e-05	0.000354	CcSEcCtD
Reboxetine—Body temperature increased—Captopril—coronary artery disease	9.58e-05	0.000353	CcSEcCtD
Reboxetine—Abdominal pain—Captopril—coronary artery disease	9.58e-05	0.000353	CcSEcCtD
Reboxetine—Dizziness—Simvastatin—coronary artery disease	9.55e-05	0.000353	CcSEcCtD
Reboxetine—Rash—Ezetimibe—coronary artery disease	9.55e-05	0.000353	CcSEcCtD
Reboxetine—Dermatitis—Ezetimibe—coronary artery disease	9.54e-05	0.000352	CcSEcCtD
Reboxetine—Confusional state—Ramipril—coronary artery disease	9.54e-05	0.000352	CcSEcCtD
Reboxetine—Discomfort—Timolol—coronary artery disease	9.53e-05	0.000352	CcSEcCtD
Reboxetine—Asthenia—Niacin—coronary artery disease	9.52e-05	0.000351	CcSEcCtD
Reboxetine—Headache—Ezetimibe—coronary artery disease	9.49e-05	0.00035	CcSEcCtD
Reboxetine—Malaise—Lisinopril—coronary artery disease	9.48e-05	0.00035	CcSEcCtD
Reboxetine—Vertigo—Lisinopril—coronary artery disease	9.44e-05	0.000349	CcSEcCtD
Reboxetine—Dry mouth—Timolol—coronary artery disease	9.43e-05	0.000348	CcSEcCtD
Reboxetine—Constipation—Losartan—coronary artery disease	9.43e-05	0.000348	CcSEcCtD
Reboxetine—Syncope—Lisinopril—coronary artery disease	9.43e-05	0.000348	CcSEcCtD
Reboxetine—Vomiting—Eplerenone—coronary artery disease	9.43e-05	0.000348	CcSEcCtD
Reboxetine—Feeling abnormal—Furosemide—coronary artery disease	9.42e-05	0.000348	CcSEcCtD
Reboxetine—Leukopenia—Lisinopril—coronary artery disease	9.41e-05	0.000347	CcSEcCtD
Reboxetine—Nausea—Fenofibrate—coronary artery disease	9.39e-05	0.000347	CcSEcCtD
Reboxetine—Asthenia—Pravastatin—coronary artery disease	9.37e-05	0.000346	CcSEcCtD
Reboxetine—Gastrointestinal pain—Furosemide—coronary artery disease	9.35e-05	0.000345	CcSEcCtD
Reboxetine—Rash—Eplerenone—coronary artery disease	9.35e-05	0.000345	CcSEcCtD
Reboxetine—Urticaria—Perindopril—coronary artery disease	9.34e-05	0.000345	CcSEcCtD
Reboxetine—Hypersensitivity—Trandolapril—coronary artery disease	9.34e-05	0.000345	CcSEcCtD
Reboxetine—Dermatitis—Eplerenone—coronary artery disease	9.34e-05	0.000345	CcSEcCtD
Reboxetine—Diarrhoea—Valsartan—coronary artery disease	9.33e-05	0.000345	CcSEcCtD
Reboxetine—Confusional state—Timolol—coronary artery disease	9.32e-05	0.000344	CcSEcCtD
Reboxetine—Shock—Ramipril—coronary artery disease	9.31e-05	0.000344	CcSEcCtD
Reboxetine—Hypersensitivity—Enalapril—coronary artery disease	9.31e-05	0.000343	CcSEcCtD
Reboxetine—Abdominal pain—Perindopril—coronary artery disease	9.3e-05	0.000343	CcSEcCtD
Reboxetine—Body temperature increased—Perindopril—coronary artery disease	9.3e-05	0.000343	CcSEcCtD
Reboxetine—Palpitations—Lisinopril—coronary artery disease	9.29e-05	0.000343	CcSEcCtD
Reboxetine—Diarrhoea—Olmesartan—coronary artery disease	9.29e-05	0.000343	CcSEcCtD
Reboxetine—Headache—Eplerenone—coronary artery disease	9.29e-05	0.000343	CcSEcCtD
Reboxetine—Nervous system disorder—Ramipril—coronary artery disease	9.28e-05	0.000342	CcSEcCtD
Reboxetine—Loss of consciousness—Lisinopril—coronary artery disease	9.24e-05	0.000341	CcSEcCtD
Reboxetine—Nausea—Clopidogrel—coronary artery disease	9.23e-05	0.000341	CcSEcCtD
Reboxetine—Tachycardia—Ramipril—coronary artery disease	9.23e-05	0.000341	CcSEcCtD
Reboxetine—Skin disorder—Ramipril—coronary artery disease	9.19e-05	0.000339	CcSEcCtD
Reboxetine—Infection—Timolol—coronary artery disease	9.19e-05	0.000339	CcSEcCtD
Reboxetine—Vomiting—Simvastatin—coronary artery disease	9.18e-05	0.000339	CcSEcCtD
Reboxetine—Hypersensitivity—Telmisartan—coronary artery disease	9.18e-05	0.000339	CcSEcCtD
Reboxetine—Nausea—Lovastatin—coronary artery disease	9.17e-05	0.000339	CcSEcCtD
Reboxetine—Hyperhidrosis—Ramipril—coronary artery disease	9.15e-05	0.000338	CcSEcCtD
Reboxetine—Rash—Simvastatin—coronary artery disease	9.11e-05	0.000336	CcSEcCtD
Reboxetine—Dermatitis—Simvastatin—coronary artery disease	9.1e-05	0.000336	CcSEcCtD
Reboxetine—Asthenia—Trandolapril—coronary artery disease	9.1e-05	0.000336	CcSEcCtD
Reboxetine—Shock—Timolol—coronary artery disease	9.1e-05	0.000336	CcSEcCtD
Reboxetine—Feeling abnormal—Losartan—coronary artery disease	9.09e-05	0.000336	CcSEcCtD
Reboxetine—Urticaria—Furosemide—coronary artery disease	9.08e-05	0.000335	CcSEcCtD
Reboxetine—Diarrhoea—Niacin—coronary artery disease	9.08e-05	0.000335	CcSEcCtD
Reboxetine—Nervous system disorder—Timolol—coronary artery disease	9.07e-05	0.000335	CcSEcCtD
Reboxetine—Asthenia—Enalapril—coronary artery disease	9.06e-05	0.000334	CcSEcCtD
Reboxetine—Headache—Simvastatin—coronary artery disease	9.05e-05	0.000334	CcSEcCtD
Reboxetine—Body temperature increased—Furosemide—coronary artery disease	9.04e-05	0.000334	CcSEcCtD
Reboxetine—Abdominal pain—Furosemide—coronary artery disease	9.04e-05	0.000334	CcSEcCtD
Reboxetine—Gastrointestinal pain—Losartan—coronary artery disease	9.02e-05	0.000333	CcSEcCtD
Reboxetine—Dizziness—Valsartan—coronary artery disease	9.02e-05	0.000333	CcSEcCtD
Reboxetine—Anorexia—Ramipril—coronary artery disease	9.02e-05	0.000333	CcSEcCtD
Reboxetine—Nausea—Ezetimibe—coronary artery disease	9e-05	0.000332	CcSEcCtD
Reboxetine—Skin disorder—Timolol—coronary artery disease	8.98e-05	0.000332	CcSEcCtD
Reboxetine—Dizziness—Olmesartan—coronary artery disease	8.98e-05	0.000331	CcSEcCtD
Reboxetine—Chest pain—Lisinopril—coronary artery disease	8.95e-05	0.00033	CcSEcCtD
Reboxetine—Hyperhidrosis—Timolol—coronary artery disease	8.94e-05	0.00033	CcSEcCtD
Reboxetine—Asthenia—Telmisartan—coronary artery disease	8.94e-05	0.00033	CcSEcCtD
Reboxetine—Diarrhoea—Pravastatin—coronary artery disease	8.94e-05	0.00033	CcSEcCtD
Reboxetine—Anxiety—Lisinopril—coronary artery disease	8.92e-05	0.000329	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.89e-05	0.000328	CcSEcCtD
Reboxetine—Discomfort—Lisinopril—coronary artery disease	8.84e-05	0.000326	CcSEcCtD
Reboxetine—Hypotension—Ramipril—coronary artery disease	8.84e-05	0.000326	CcSEcCtD
Reboxetine—Anorexia—Timolol—coronary artery disease	8.82e-05	0.000325	CcSEcCtD
Reboxetine—Nausea—Eplerenone—coronary artery disease	8.81e-05	0.000325	CcSEcCtD
Reboxetine—Dizziness—Niacin—coronary artery disease	8.77e-05	0.000324	CcSEcCtD
Reboxetine—Urticaria—Losartan—coronary artery disease	8.76e-05	0.000323	CcSEcCtD
Reboxetine—Dry mouth—Lisinopril—coronary artery disease	8.75e-05	0.000323	CcSEcCtD
Reboxetine—Abdominal pain—Losartan—coronary artery disease	8.72e-05	0.000322	CcSEcCtD
Reboxetine—Body temperature increased—Losartan—coronary artery disease	8.72e-05	0.000322	CcSEcCtD
Reboxetine—Asthenia—Captopril—coronary artery disease	8.69e-05	0.000321	CcSEcCtD
Reboxetine—Diarrhoea—Trandolapril—coronary artery disease	8.68e-05	0.00032	CcSEcCtD
Reboxetine—Vomiting—Valsartan—coronary artery disease	8.67e-05	0.00032	CcSEcCtD
Reboxetine—Confusional state—Lisinopril—coronary artery disease	8.65e-05	0.000319	CcSEcCtD
Reboxetine—Diarrhoea—Enalapril—coronary artery disease	8.64e-05	0.000319	CcSEcCtD
Reboxetine—Hypotension—Timolol—coronary artery disease	8.64e-05	0.000319	CcSEcCtD
Reboxetine—Dizziness—Pravastatin—coronary artery disease	8.64e-05	0.000319	CcSEcCtD
Reboxetine—Vomiting—Olmesartan—coronary artery disease	8.63e-05	0.000319	CcSEcCtD
Reboxetine—Rash—Valsartan—coronary artery disease	8.6e-05	0.000317	CcSEcCtD
Reboxetine—Dermatitis—Valsartan—coronary artery disease	8.59e-05	0.000317	CcSEcCtD
Reboxetine—Nausea—Simvastatin—coronary artery disease	8.58e-05	0.000317	CcSEcCtD
Reboxetine—Rash—Olmesartan—coronary artery disease	8.56e-05	0.000316	CcSEcCtD
Reboxetine—Insomnia—Ramipril—coronary artery disease	8.56e-05	0.000316	CcSEcCtD
Reboxetine—Dermatitis—Olmesartan—coronary artery disease	8.55e-05	0.000316	CcSEcCtD
Reboxetine—Headache—Valsartan—coronary artery disease	8.55e-05	0.000315	CcSEcCtD
Reboxetine—Diarrhoea—Telmisartan—coronary artery disease	8.52e-05	0.000315	CcSEcCtD
Reboxetine—Infection—Lisinopril—coronary artery disease	8.52e-05	0.000315	CcSEcCtD
Reboxetine—Headache—Olmesartan—coronary artery disease	8.5e-05	0.000314	CcSEcCtD
Reboxetine—Paraesthesia—Ramipril—coronary artery disease	8.49e-05	0.000314	CcSEcCtD
Reboxetine—Shock—Lisinopril—coronary artery disease	8.44e-05	0.000312	CcSEcCtD
Reboxetine—Asthenia—Perindopril—coronary artery disease	8.44e-05	0.000311	CcSEcCtD
Reboxetine—Dyspnoea—Ramipril—coronary artery disease	8.43e-05	0.000311	CcSEcCtD
Reboxetine—Vomiting—Niacin—coronary artery disease	8.43e-05	0.000311	CcSEcCtD
Reboxetine—Hypersensitivity—Furosemide—coronary artery disease	8.42e-05	0.000311	CcSEcCtD
Reboxetine—Somnolence—Ramipril—coronary artery disease	8.41e-05	0.00031	CcSEcCtD
Reboxetine—Dizziness—Trandolapril—coronary artery disease	8.39e-05	0.00031	CcSEcCtD
Reboxetine—Tachycardia—Lisinopril—coronary artery disease	8.37e-05	0.000309	CcSEcCtD
Reboxetine—Insomnia—Timolol—coronary artery disease	8.36e-05	0.000309	CcSEcCtD
Reboxetine—Rash—Niacin—coronary artery disease	8.36e-05	0.000309	CcSEcCtD
Reboxetine—Dermatitis—Niacin—coronary artery disease	8.36e-05	0.000308	CcSEcCtD
Reboxetine—Dizziness—Enalapril—coronary artery disease	8.35e-05	0.000308	CcSEcCtD
Reboxetine—Skin disorder—Lisinopril—coronary artery disease	8.33e-05	0.000308	CcSEcCtD
Reboxetine—Dyspepsia—Ramipril—coronary artery disease	8.33e-05	0.000307	CcSEcCtD
Reboxetine—Headache—Niacin—coronary artery disease	8.31e-05	0.000307	CcSEcCtD
Reboxetine—Paraesthesia—Timolol—coronary artery disease	8.3e-05	0.000307	CcSEcCtD
Reboxetine—Vomiting—Pravastatin—coronary artery disease	8.3e-05	0.000306	CcSEcCtD
Reboxetine—Hyperhidrosis—Lisinopril—coronary artery disease	8.29e-05	0.000306	CcSEcCtD
Reboxetine—Diarrhoea—Captopril—coronary artery disease	8.29e-05	0.000306	CcSEcCtD
Reboxetine—Dyspnoea—Timolol—coronary artery disease	8.25e-05	0.000304	CcSEcCtD
Reboxetine—Dizziness—Telmisartan—coronary artery disease	8.24e-05	0.000304	CcSEcCtD
Reboxetine—Rash—Pravastatin—coronary artery disease	8.23e-05	0.000304	CcSEcCtD
Reboxetine—Dermatitis—Pravastatin—coronary artery disease	8.23e-05	0.000304	CcSEcCtD
Reboxetine—Decreased appetite—Ramipril—coronary artery disease	8.22e-05	0.000304	CcSEcCtD
Reboxetine—Somnolence—Timolol—coronary artery disease	8.22e-05	0.000303	CcSEcCtD
Reboxetine—Asthenia—Furosemide—coronary artery disease	8.2e-05	0.000303	CcSEcCtD
Reboxetine—Headache—Pravastatin—coronary artery disease	8.18e-05	0.000302	CcSEcCtD
Reboxetine—Anorexia—Lisinopril—coronary artery disease	8.18e-05	0.000302	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Ramipril—coronary artery disease	8.17e-05	0.000301	CcSEcCtD
Reboxetine—Dyspepsia—Timolol—coronary artery disease	8.14e-05	0.0003	CcSEcCtD
Reboxetine—Hypersensitivity—Losartan—coronary artery disease	8.13e-05	0.0003	CcSEcCtD
Reboxetine—Nausea—Valsartan—coronary artery disease	8.1e-05	0.000299	CcSEcCtD
Reboxetine—Constipation—Ramipril—coronary artery disease	8.09e-05	0.000299	CcSEcCtD
Reboxetine—Nausea—Olmesartan—coronary artery disease	8.06e-05	0.000298	CcSEcCtD
Reboxetine—Vomiting—Trandolapril—coronary artery disease	8.06e-05	0.000298	CcSEcCtD
Reboxetine—Diarrhoea—Perindopril—coronary artery disease	8.05e-05	0.000297	CcSEcCtD
Reboxetine—Decreased appetite—Timolol—coronary artery disease	8.04e-05	0.000297	CcSEcCtD
Reboxetine—Vomiting—Enalapril—coronary artery disease	8.03e-05	0.000296	CcSEcCtD
Reboxetine—Hypotension—Lisinopril—coronary artery disease	8.02e-05	0.000296	CcSEcCtD
Reboxetine—Dizziness—Captopril—coronary artery disease	8.01e-05	0.000296	CcSEcCtD
Reboxetine—Rash—Trandolapril—coronary artery disease	8e-05	0.000295	CcSEcCtD
Reboxetine—Dermatitis—Trandolapril—coronary artery disease	7.99e-05	0.000295	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Timolol—coronary artery disease	7.98e-05	0.000295	CcSEcCtD
Reboxetine—Rash—Enalapril—coronary artery disease	7.96e-05	0.000294	CcSEcCtD
Reboxetine—Dermatitis—Enalapril—coronary artery disease	7.96e-05	0.000294	CcSEcCtD
Reboxetine—Headache—Trandolapril—coronary artery disease	7.94e-05	0.000293	CcSEcCtD
Reboxetine—Vomiting—Telmisartan—coronary artery disease	7.92e-05	0.000292	CcSEcCtD
Reboxetine—Asthenia—Losartan—coronary artery disease	7.92e-05	0.000292	CcSEcCtD
Reboxetine—Headache—Enalapril—coronary artery disease	7.91e-05	0.000292	CcSEcCtD
Reboxetine—Nausea—Niacin—coronary artery disease	7.88e-05	0.000291	CcSEcCtD
Reboxetine—Rash—Telmisartan—coronary artery disease	7.86e-05	0.00029	CcSEcCtD
Reboxetine—Dermatitis—Telmisartan—coronary artery disease	7.85e-05	0.00029	CcSEcCtD
Reboxetine—Diarrhoea—Furosemide—coronary artery disease	7.82e-05	0.000289	CcSEcCtD
Reboxetine—Headache—Telmisartan—coronary artery disease	7.8e-05	0.000288	CcSEcCtD
Reboxetine—Feeling abnormal—Ramipril—coronary artery disease	7.8e-05	0.000288	CcSEcCtD
Reboxetine—Dizziness—Perindopril—coronary artery disease	7.78e-05	0.000287	CcSEcCtD
Reboxetine—Insomnia—Lisinopril—coronary artery disease	7.76e-05	0.000286	CcSEcCtD
Reboxetine—Nausea—Pravastatin—coronary artery disease	7.76e-05	0.000286	CcSEcCtD
Reboxetine—Gastrointestinal pain—Ramipril—coronary artery disease	7.74e-05	0.000286	CcSEcCtD
Reboxetine—Paraesthesia—Lisinopril—coronary artery disease	7.7e-05	0.000284	CcSEcCtD
Reboxetine—Vomiting—Captopril—coronary artery disease	7.7e-05	0.000284	CcSEcCtD
Reboxetine—Dyspnoea—Lisinopril—coronary artery disease	7.65e-05	0.000282	CcSEcCtD
Reboxetine—Rash—Captopril—coronary artery disease	7.64e-05	0.000282	CcSEcCtD
Reboxetine—Dermatitis—Captopril—coronary artery disease	7.63e-05	0.000282	CcSEcCtD
Reboxetine—Somnolence—Lisinopril—coronary artery disease	7.63e-05	0.000282	CcSEcCtD
Reboxetine—Feeling abnormal—Timolol—coronary artery disease	7.62e-05	0.000281	CcSEcCtD
Reboxetine—Headache—Captopril—coronary artery disease	7.59e-05	0.00028	CcSEcCtD
Reboxetine—Gastrointestinal pain—Timolol—coronary artery disease	7.56e-05	0.000279	CcSEcCtD
Reboxetine—Dizziness—Furosemide—coronary artery disease	7.56e-05	0.000279	CcSEcCtD
Reboxetine—Dyspepsia—Lisinopril—coronary artery disease	7.55e-05	0.000279	CcSEcCtD
Reboxetine—Diarrhoea—Losartan—coronary artery disease	7.55e-05	0.000279	CcSEcCtD
Reboxetine—Nausea—Trandolapril—coronary artery disease	7.53e-05	0.000278	CcSEcCtD
Reboxetine—Urticaria—Ramipril—coronary artery disease	7.52e-05	0.000277	CcSEcCtD
Reboxetine—Nausea—Enalapril—coronary artery disease	7.5e-05	0.000277	CcSEcCtD
Reboxetine—Vomiting—Perindopril—coronary artery disease	7.48e-05	0.000276	CcSEcCtD
Reboxetine—Abdominal pain—Ramipril—coronary artery disease	7.48e-05	0.000276	CcSEcCtD
Reboxetine—Body temperature increased—Ramipril—coronary artery disease	7.48e-05	0.000276	CcSEcCtD
Reboxetine—Decreased appetite—Lisinopril—coronary artery disease	7.46e-05	0.000275	CcSEcCtD
Reboxetine—Rash—Perindopril—coronary artery disease	7.42e-05	0.000274	CcSEcCtD
Reboxetine—Dermatitis—Perindopril—coronary artery disease	7.41e-05	0.000273	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.41e-05	0.000273	CcSEcCtD
Reboxetine—Nausea—Telmisartan—coronary artery disease	7.4e-05	0.000273	CcSEcCtD
Reboxetine—Headache—Perindopril—coronary artery disease	7.37e-05	0.000272	CcSEcCtD
Reboxetine—Urticaria—Timolol—coronary artery disease	7.35e-05	0.000271	CcSEcCtD
Reboxetine—Constipation—Lisinopril—coronary artery disease	7.34e-05	0.000271	CcSEcCtD
Reboxetine—Body temperature increased—Timolol—coronary artery disease	7.31e-05	0.00027	CcSEcCtD
Reboxetine—Abdominal pain—Timolol—coronary artery disease	7.31e-05	0.00027	CcSEcCtD
Reboxetine—Dizziness—Losartan—coronary artery disease	7.3e-05	0.000269	CcSEcCtD
Reboxetine—Vomiting—Furosemide—coronary artery disease	7.27e-05	0.000268	CcSEcCtD
Reboxetine—Rash—Furosemide—coronary artery disease	7.21e-05	0.000266	CcSEcCtD
Reboxetine—Dermatitis—Furosemide—coronary artery disease	7.2e-05	0.000266	CcSEcCtD
Reboxetine—Nausea—Captopril—coronary artery disease	7.2e-05	0.000266	CcSEcCtD
Reboxetine—Headache—Furosemide—coronary artery disease	7.16e-05	0.000264	CcSEcCtD
Reboxetine—Feeling abnormal—Lisinopril—coronary artery disease	7.07e-05	0.000261	CcSEcCtD
Reboxetine—Gastrointestinal pain—Lisinopril—coronary artery disease	7.02e-05	0.000259	CcSEcCtD
Reboxetine—Vomiting—Losartan—coronary artery disease	7.01e-05	0.000259	CcSEcCtD
Reboxetine—Nausea—Perindopril—coronary artery disease	6.99e-05	0.000258	CcSEcCtD
Reboxetine—Hypersensitivity—Ramipril—coronary artery disease	6.97e-05	0.000257	CcSEcCtD
Reboxetine—Rash—Losartan—coronary artery disease	6.96e-05	0.000257	CcSEcCtD
Reboxetine—Dermatitis—Losartan—coronary artery disease	6.95e-05	0.000257	CcSEcCtD
Reboxetine—Headache—Losartan—coronary artery disease	6.91e-05	0.000255	CcSEcCtD
Reboxetine—Urticaria—Lisinopril—coronary artery disease	6.82e-05	0.000252	CcSEcCtD
Reboxetine—Hypersensitivity—Timolol—coronary artery disease	6.81e-05	0.000251	CcSEcCtD
Reboxetine—Nausea—Furosemide—coronary artery disease	6.79e-05	0.000251	CcSEcCtD
Reboxetine—Asthenia—Ramipril—coronary artery disease	6.79e-05	0.000251	CcSEcCtD
Reboxetine—Abdominal pain—Lisinopril—coronary artery disease	6.78e-05	0.00025	CcSEcCtD
Reboxetine—Body temperature increased—Lisinopril—coronary artery disease	6.78e-05	0.00025	CcSEcCtD
Reboxetine—Asthenia—Timolol—coronary artery disease	6.64e-05	0.000245	CcSEcCtD
Reboxetine—Nausea—Losartan—coronary artery disease	6.55e-05	0.000242	CcSEcCtD
Reboxetine—Diarrhoea—Ramipril—coronary artery disease	6.47e-05	0.000239	CcSEcCtD
Reboxetine—Diarrhoea—Timolol—coronary artery disease	6.33e-05	0.000234	CcSEcCtD
Reboxetine—Hypersensitivity—Lisinopril—coronary artery disease	6.32e-05	0.000233	CcSEcCtD
Reboxetine—Dizziness—Ramipril—coronary artery disease	6.26e-05	0.000231	CcSEcCtD
Reboxetine—Asthenia—Lisinopril—coronary artery disease	6.16e-05	0.000227	CcSEcCtD
Reboxetine—Dizziness—Timolol—coronary artery disease	6.12e-05	0.000226	CcSEcCtD
Reboxetine—Vomiting—Ramipril—coronary artery disease	6.01e-05	0.000222	CcSEcCtD
Reboxetine—Rash—Ramipril—coronary artery disease	5.96e-05	0.00022	CcSEcCtD
Reboxetine—Dermatitis—Ramipril—coronary artery disease	5.96e-05	0.00022	CcSEcCtD
Reboxetine—Headache—Ramipril—coronary artery disease	5.93e-05	0.000219	CcSEcCtD
Reboxetine—Vomiting—Timolol—coronary artery disease	5.88e-05	0.000217	CcSEcCtD
Reboxetine—Diarrhoea—Lisinopril—coronary artery disease	5.87e-05	0.000217	CcSEcCtD
Reboxetine—Rash—Timolol—coronary artery disease	5.83e-05	0.000215	CcSEcCtD
Reboxetine—Dermatitis—Timolol—coronary artery disease	5.83e-05	0.000215	CcSEcCtD
Reboxetine—Headache—Timolol—coronary artery disease	5.79e-05	0.000214	CcSEcCtD
Reboxetine—Dizziness—Lisinopril—coronary artery disease	5.67e-05	0.000209	CcSEcCtD
Reboxetine—Nausea—Ramipril—coronary artery disease	5.62e-05	0.000207	CcSEcCtD
Reboxetine—Nausea—Timolol—coronary artery disease	5.49e-05	0.000203	CcSEcCtD
Reboxetine—Vomiting—Lisinopril—coronary artery disease	5.45e-05	0.000201	CcSEcCtD
Reboxetine—Rash—Lisinopril—coronary artery disease	5.41e-05	0.0002	CcSEcCtD
Reboxetine—Dermatitis—Lisinopril—coronary artery disease	5.4e-05	0.000199	CcSEcCtD
Reboxetine—Headache—Lisinopril—coronary artery disease	5.37e-05	0.000198	CcSEcCtD
Reboxetine—Nausea—Lisinopril—coronary artery disease	5.1e-05	0.000188	CcSEcCtD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	1.08e-05	0.000147	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLCB3—coronary artery disease	1.07e-05	0.000145	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ITGAV—coronary artery disease	1.07e-05	0.000145	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KNG1—coronary artery disease	1.07e-05	0.000145	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CREB1—coronary artery disease	1.06e-05	0.000144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—POMC—coronary artery disease	1.06e-05	0.000144	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOA5—coronary artery disease	1.06e-05	0.000144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AGTR1—coronary artery disease	1.06e-05	0.000144	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.06e-05	0.000143	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.06e-05	0.000143	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DLAT—coronary artery disease	1.06e-05	0.000143	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—COX5B—coronary artery disease	1.06e-05	0.000143	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.06e-05	0.000143	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—P4HB—coronary artery disease	1.04e-05	0.000141	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCL2—coronary artery disease	1.04e-05	0.000141	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6R—coronary artery disease	1.04e-05	0.000141	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL10—coronary artery disease	1.04e-05	0.00014	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLG—coronary artery disease	1.03e-05	0.00014	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—VCAN—coronary artery disease	1.02e-05	0.000139	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	1.02e-05	0.000139	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALDOA—coronary artery disease	1.02e-05	0.000138	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.01e-05	0.000137	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRB2—coronary artery disease	1.01e-05	0.000136	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1e-05	0.000136	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCE—coronary artery disease	9.94e-06	0.000135	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—JAK2—coronary artery disease	9.93e-06	0.000135	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SOCS1—coronary artery disease	9.91e-06	0.000134	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—S100B—coronary artery disease	9.89e-06	0.000134	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—DCN—coronary artery disease	9.86e-06	0.000134	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SOCS3—coronary artery disease	9.79e-06	0.000133	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KITLG—coronary artery disease	9.68e-06	0.000131	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFBR2—coronary artery disease	9.68e-06	0.000131	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—VCAN—coronary artery disease	9.64e-06	0.000131	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALDH2—coronary artery disease	9.59e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDOA—coronary artery disease	9.57e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	9.56e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HK2—coronary artery disease	9.56e-06	0.00013	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT5A—coronary artery disease	9.46e-06	0.000128	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP3—coronary artery disease	9.46e-06	0.000128	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LIPC—coronary artery disease	9.34e-06	0.000127	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HBA1—coronary artery disease	9.34e-06	0.000127	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP2C19—coronary artery disease	9.34e-06	0.000127	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3C2A—coronary artery disease	9.34e-06	0.000127	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—DCN—coronary artery disease	9.29e-06	0.000126	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOC3—coronary artery disease	9.29e-06	0.000126	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LDLR—coronary artery disease	9.23e-06	0.000125	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	9.17e-06	0.000124	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOB—coronary artery disease	9.14e-06	0.000124	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC9A1—coronary artery disease	9.12e-06	0.000124	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTT1—coronary artery disease	9.12e-06	0.000124	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCL8—coronary artery disease	9.06e-06	0.000123	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALDH2—coronary artery disease	9.04e-06	0.000122	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—JAK2—coronary artery disease	9.02e-06	0.000122	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GCLC—coronary artery disease	9.02e-06	0.000122	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CETP—coronary artery disease	9.02e-06	0.000122	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EDN1—coronary artery disease	9e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LCAT—coronary artery disease	8.99e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CPT1B—coronary artery disease	8.99e-06	0.000122	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL5—coronary artery disease	8.93e-06	0.000121	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SDC1—coronary artery disease	8.91e-06	0.000121	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	8.85e-06	0.00012	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA4—coronary artery disease	8.83e-06	0.00012	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LIPC—coronary artery disease	8.81e-06	0.000119	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HBA1—coronary artery disease	8.81e-06	0.000119	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	8.81e-06	0.000119	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	8.81e-06	0.000119	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CSF2—coronary artery disease	8.79e-06	0.000119	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF1—coronary artery disease	8.79e-06	0.000119	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOC3—coronary artery disease	8.75e-06	0.000119	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LPL—coronary artery disease	8.73e-06	0.000118	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LDLR—coronary artery disease	8.7e-06	0.000118	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RPS6KB1—coronary artery disease	8.65e-06	0.000117	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MEF2C—coronary artery disease	8.65e-06	0.000117	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	8.59e-06	0.000116	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTT1—coronary artery disease	8.59e-06	0.000116	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PDHA1—coronary artery disease	8.52e-06	0.000115	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GCLM—coronary artery disease	8.52e-06	0.000115	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GCLC—coronary artery disease	8.5e-06	0.000115	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CETP—coronary artery disease	8.5e-06	0.000115	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ITGB3—coronary artery disease	8.43e-06	0.000114	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PSMB5—coronary artery disease	8.42e-06	0.000114	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PSMA6—coronary artery disease	8.42e-06	0.000114	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SDC1—coronary artery disease	8.4e-06	0.000114	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	8.25e-06	0.000112	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	8.25e-06	0.000112	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL8—coronary artery disease	8.23e-06	0.000112	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CTGF—coronary artery disease	8.23e-06	0.000111	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PPP2CA—coronary artery disease	8.19e-06	0.000111	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMGCR—coronary artery disease	8.15e-06	0.00011	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GOT2—coronary artery disease	8.15e-06	0.00011	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	8.13e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCD—coronary artery disease	8.04e-06	0.000109	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ARNTL—coronary artery disease	8.01e-06	0.000109	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HADH—coronary artery disease	8.01e-06	0.000109	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	7.99e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PSMA6—coronary artery disease	7.94e-06	0.000108	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PSMB5—coronary artery disease	7.94e-06	0.000108	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—coronary artery disease	7.87e-06	0.000107	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—C3—coronary artery disease	7.86e-06	0.000106	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CTGF—coronary artery disease	7.75e-06	0.000105	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GOT2—coronary artery disease	7.68e-06	0.000104	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMGCR—coronary artery disease	7.68e-06	0.000104	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	7.6e-06	0.000103	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA2—coronary artery disease	7.6e-06	0.000103	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX2—coronary artery disease	7.6e-06	0.000103	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	7.5e-06	0.000102	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX4—coronary artery disease	7.5e-06	0.000102	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG5—coronary artery disease	7.5e-06	0.000102	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HK1—coronary artery disease	7.5e-06	0.000102	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLCB1—coronary artery disease	7.5e-06	0.000102	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HIF1A—coronary artery disease	7.49e-06	0.000102	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AGT—coronary artery disease	7.47e-06	0.000101	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HADHA—coronary artery disease	7.41e-06	0.0001	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTA1—coronary artery disease	7.33e-06	9.93e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOE—coronary artery disease	7.32e-06	9.91e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LEP—coronary artery disease	7.32e-06	9.91e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCA1—coronary artery disease	7.27e-06	9.85e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LPA—coronary artery disease	7.25e-06	9.82e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOA1—coronary artery disease	7.23e-06	9.8e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KDR—coronary artery disease	7.17e-06	9.71e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK14—coronary artery disease	7.12e-06	9.65e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLCB1—coronary artery disease	7.06e-06	9.57e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GOT1—coronary artery disease	7.04e-06	9.54e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GGT1—coronary artery disease	7.04e-06	9.54e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLCB3—coronary artery disease	7.02e-06	9.51e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ESR1—coronary artery disease	6.98e-06	9.46e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA5—coronary artery disease	6.95e-06	9.41e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FN1—coronary artery disease	6.9e-06	9.35e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—F2—coronary artery disease	6.9e-06	9.35e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6ST—coronary artery disease	6.87e-06	9.31e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCA1—coronary artery disease	6.85e-06	9.28e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NFKBIA—coronary artery disease	6.82e-06	9.24e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—P4HB—coronary artery disease	6.81e-06	9.23e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	6.69e-06	9.06e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GGT1—coronary artery disease	6.63e-06	8.99e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GOT1—coronary artery disease	6.63e-06	8.99e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KIT—coronary artery disease	6.6e-06	8.95e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GSK3B—coronary artery disease	6.34e-06	8.58e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTP1—coronary artery disease	6.32e-06	8.57e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—VCAN—coronary artery disease	6.3e-06	8.54e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—POMC—coronary artery disease	6.28e-06	8.52e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CREB1—coronary artery disease	6.28e-06	8.52e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	6.26e-06	8.49e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDOA—coronary artery disease	6.26e-06	8.48e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMOX1—coronary artery disease	6.23e-06	8.45e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CAT—coronary artery disease	6.15e-06	8.34e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL2—coronary artery disease	6.15e-06	8.33e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6R—coronary artery disease	6.13e-06	8.31e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DCN—coronary artery disease	6.07e-06	8.23e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1—coronary artery disease	6.05e-06	8.19e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAPK1—coronary artery disease	6.02e-06	8.15e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOB—coronary artery disease	5.97e-06	8.09e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTP1—coronary artery disease	5.96e-06	8.07e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALDH2—coronary artery disease	5.91e-06	8e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	5.9e-06	8e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMOX1—coronary artery disease	5.88e-06	7.96e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTM1—coronary artery disease	5.81e-06	7.87e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CAT—coronary artery disease	5.8e-06	7.85e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HBA1—coronary artery disease	5.76e-06	7.8e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	5.76e-06	7.8e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	5.76e-06	7.8e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LIPC—coronary artery disease	5.76e-06	7.8e-05	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	5.75e-06	7.79e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	5.74e-06	7.78e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOC3—coronary artery disease	5.72e-06	7.75e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LPL—coronary artery disease	5.7e-06	7.73e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LDLR—coronary artery disease	5.69e-06	7.71e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOB—coronary artery disease	5.63e-06	7.63e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTT1—coronary artery disease	5.62e-06	7.61e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	5.62e-06	7.61e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GPX1—coronary artery disease	5.56e-06	7.54e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF2—coronary artery disease	5.56e-06	7.53e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GCLC—coronary artery disease	5.55e-06	7.53e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CETP—coronary artery disease	5.55e-06	7.53e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SDC1—coronary artery disease	5.49e-06	7.44e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOS3—coronary artery disease	5.48e-06	7.43e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTM1—coronary artery disease	5.47e-06	7.42e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CD36—coronary artery disease	5.42e-06	7.34e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LPL—coronary artery disease	5.37e-06	7.28e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPP2CA—coronary artery disease	5.35e-06	7.25e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	5.33e-06	7.22e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GPX1—coronary artery disease	5.24e-06	7.1e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	5.22e-06	7.07e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PSMA6—coronary artery disease	5.19e-06	7.03e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PSMB5—coronary artery disease	5.19e-06	7.03e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—coronary artery disease	5.13e-06	6.96e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CD36—coronary artery disease	5.11e-06	6.92e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CTGF—coronary artery disease	5.07e-06	6.87e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	5.04e-06	6.83e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GOT2—coronary artery disease	5.02e-06	6.81e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMGCR—coronary artery disease	5.02e-06	6.81e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AGT—coronary artery disease	4.88e-06	6.61e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	4.86e-06	6.59e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.84e-06	6.56e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOE—coronary artery disease	4.78e-06	6.48e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOA1—coronary artery disease	4.73e-06	6.4e-05	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	4.7e-06	6.36e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	4.65e-06	6.3e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	4.62e-06	6.26e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLCB1—coronary artery disease	4.62e-06	6.26e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AGT—coronary artery disease	4.6e-06	6.23e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	4.53e-06	6.14e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOE—coronary artery disease	4.5e-06	6.1e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCA1—coronary artery disease	4.48e-06	6.07e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOA1—coronary artery disease	4.45e-06	6.03e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	4.4e-06	5.96e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GGT1—coronary artery disease	4.34e-06	5.88e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GOT1—coronary artery disease	4.34e-06	5.88e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	4.27e-06	5.78e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARG—coronary artery disease	4.16e-06	5.64e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—POMC—coronary artery disease	4.11e-06	5.56e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	3.95e-06	5.35e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARG—coronary artery disease	3.92e-06	5.32e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.89e-06	5.28e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—POMC—coronary artery disease	3.87e-06	5.24e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.86e-06	5.23e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.84e-06	5.2e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CAT—coronary artery disease	3.79e-06	5.14e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—coronary artery disease	3.74e-06	5.07e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOB—coronary artery disease	3.68e-06	4.99e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	3.62e-06	4.91e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NOS3—coronary artery disease	3.58e-06	4.85e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.58e-06	4.85e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	3.55e-06	4.82e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—coronary artery disease	3.53e-06	4.78e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LPL—coronary artery disease	3.51e-06	4.76e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX1—coronary artery disease	3.43e-06	4.64e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NOS3—coronary artery disease	3.37e-06	4.57e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CD36—coronary artery disease	3.34e-06	4.52e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.3e-06	4.47e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—coronary artery disease	3.28e-06	4.44e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.16e-06	4.29e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.09e-06	4.18e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	3.08e-06	4.18e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AGT—coronary artery disease	3.01e-06	4.07e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOE—coronary artery disease	2.94e-06	3.99e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA1—coronary artery disease	2.91e-06	3.94e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—coronary artery disease	2.73e-06	3.7e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARG—coronary artery disease	2.57e-06	3.48e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—POMC—coronary artery disease	2.53e-06	3.43e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	2.52e-06	3.41e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—coronary artery disease	2.31e-06	3.13e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NOS3—coronary artery disease	2.21e-06	2.99e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.02e-06	2.73e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.02e-06	2.73e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.9e-06	2.57e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—coronary artery disease	1.65e-06	2.23e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.55e-06	2.1e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.24e-06	1.68e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—coronary artery disease	1.01e-06	1.37e-05	CbGpPWpGaD
